Expectations trend
FY2028 · fiscal year ending 2028-01-31 · fmp
Victoria's Secret (VSXY)
NYSEConsumer DiscretionaryApparel - RetailSnapshot 2026-11-04
$108.95+8.38%
Close 2026-11-04 · 1-day change
NYSEConsumer DiscretionaryApparel - RetailSnapshot 2026-11-04
The long-term thesis, the evidence coming in, and the environment around it. Thesis dated Jul 8, 2026.
Next-FY EPS estimate change · 30 days
5.62 → 5.67 EPS · FY ending Jan 31, 2028 · 7 analysts
One observable signal. This measures changing earnings expectations, not the probability of a gain or loss.
Change in the same fiscal period’s mean EPS estimate from Oct 5, 2026 to Nov 4, 2026: (new ÷ prior − 1). Contributor count changed from 6 to 7; this is not the number of analysts revising. The ±10% axis is a display range.
The EPS and P/E reference is not available for VSXY yet.
| Measure / period | Management expectations | Analyst expectations |
|---|
Management figures unavailable.
Current consensus figures unavailable.
4 published thesis conditions, with dated milestones shown separately.
| Key Factor | Why It Matters | Current Status | Break Condition | Latest Evidence |
|---|---|---|---|---|
EPS grows to at least $4.59 in FY27 | A supporting condition in Victoria's Secret's published investment case. The stated target is >=4.59 USD_PER_SHARE. | Intact | EPS falls below $2.33 in FY27 | Direct metric needs a verified mapping The published measure or accounting basis is not supported by an exact source binding. Date unavailableLast status assessment Nov 4, 2026Compare required operating outcomesCompare scope, accounting basis and period before treating this evidence as progress against an annual requirement. |
Compare these dated observations with the operating requirements above
FY2028 · fiscal year ending 2028-01-31 · fmp
The evidence, the remaining questions, and what comes next
No recovery evidence is reported in the available driver assessments.
Dec 4, 2026
Look for updated results and guidance against the published targets, plus direct evidence for unresolved drivers.
Observed price history; separate from operating scenarios
The weekly editorial context below is a separate assessment from the dated monitor evidence above. Recovery observations do not automatically change the published thesis. Unverified outside influences are hypotheses, not measured driver evidence.
This is a growth-focused consumer discretionary business with strong recent financial performance, rather than a turnaround story. The long-term thesis is intact, though the signal has recently shifted from mildly favorable to mixed.
VSXY is valued at a premium to peers, and the evidence labels that premium as justified, with low signs of fragility. The expectations gap is negative, suggesting expectations may be ahead of what the model supports; confidence in that reading is medium.
Near-term results have been strong, with recent revenue growth and higher full-year sales and operating income guidance. Management’s technology and digital strategy has mixed evidence, though broad-based growth and market share gains in the latest quarter support progress. Near-term earnings risk is described as low, but recent surprises have been erratic and a guidance cut would matter.
Over the next few quarters, the thesis depends on management delivering its raised sales and operating income goals. Sector bellwethers TJX, ROST, and BURL are useful signals: continued strength could support the sector backdrop, while misses or lower guidance could weaken it. A guidance cut from VSXY would be a meaningful negative.
For the 1-3 year view, recent execution supports an intact thesis, but the premium valuation and mixed signal make continued delivery central. Not investment advice.
Not investment advice. Scores describe historical and current data; they are not forecasts of future returns. Consult a licensed advisor before making investment decisions.
| The company has strong leadership and a clear growth plan with new outlets. |
| Improving |
| Failure to advance outlet plans or loss of board control |
9.0% comp sales growth vs qualitative target Q2 earnings beat, 9% comp sales growth, and raised full-year sales guidance support the thesis. Nov 4, 2026Last status assessment Nov 4, 2026Compare required operating outcomesCompare scope, accounting basis and period before treating this evidence as progress against an annual requirement. |
Operating profit near $565 million in FY27 | Profit is rising with operating margin expected near $565 million. | Intact | Operating margin falls below $265 million in FY27 | Operating margin: 15.95% FY2026-Q2; GAAP. Published target: 550-580 USD_MILLIONS. Annual target cannot be compared with a quarterly or TTM observation. Sep 4, 202615.952824 percent · calculatedLast status assessment Nov 4, 2026Compare required operating outcomesCompare scope, accounting basis and period before treating this evidence as progress against an annual requirement. |
Revenue grows to at least $7.03 billion in FY27 | A primary condition in Victoria's Secret's published investment case. The stated target is >=7.03 USD_BILLIONS. | Intact | Revenue falls below $6.37 billion in FY27 | Revenue: $1.611B FY2026-Q2; GAAP. Published target: >=7.03 USD_BILLIONS. Annual target cannot be compared with a quarterly or TTM observation. Sep 4, 20261,611,000,000 USD · source valueLast status assessment Nov 4, 2026Compare required operating outcomesCompare scope, accounting basis and period before treating this evidence as progress against an annual requirement. |
Stored thesis · Jul 8, 2026. Latest Evidence uses source-matched measurements where available, alongside the last thesis-monitor assessment. Source periods and assessment dates are shown separately. A new measurement does not automatically change the published status or verify an older target.
$5.45 → $5.67 · observed estimates
$7.45B → $7.56B · observed estimates
One fiscal period and provider throughout. At least five contributors are required for each plotted metric; missing coverage stays a gap. Axes show the observed range. Counts measure coverage, not revisions.
| Snapshot | EPS | Revenue | EPS / revenue analysts |
|---|---|---|---|
| 2026-07-24 | $5.45 | $7,445,029,447 | 5 / 7 |
| 2026-07-25 | $5.45 | $7,445,029,447 | 5 / 7 |
| 2026-07-26 | $5.45 | $7,445,029,447 | 5 / 7 |
| 2026-07-27 | $5.45 | $7,445,029,447 | 5 / 7 |
| 2026-07-28 | $5.45 | $7,445,029,447 | 5 / 7 |
| 2026-07-29 | $5.45 | $7,445,029,447 | 5 / 7 |
| 2026-07-30 | $5.46 | $7,446,229,447 | 5 / 7 |
| 2026-07-31 | $5.46 | $7,446,229,447 | 5 / 7 |
| 2026-08-01 | $5.46 | $7,446,229,447 | 5 / 7 |
| 2026-08-02 | $5.46 | $7,446,229,447 | 5 / 7 |
| 2026-08-03 | $5.46 | $7,446,229,447 | 5 / 7 |
| 2026-08-04 | $5.46 | $7,446,229,447 | 5 / 7 |
| 2026-08-05 | $5.46 | $7,446,229,447 | 5 / 7 |
| 2026-08-06 | $5.46 | $7,446,229,447 | 5 / 7 |
| 2026-08-08 | $5.46 | $7,446,229,447 | 5 / 7 |
| 2026-08-09 | $5.46 | $7,446,229,447 | 5 / 7 |
| 2026-08-10 | $5.46 | $7,446,229,447 | 5 / 7 |
| 2026-08-12 | $5.46 | $7,446,269,710 | 10 / 10 |
| 2026-08-13 | $5.46 | $7,446,229,447 | 5 / 7 |
| 2026-08-14 | $5.46 | $7,446,229,447 | 5 / 7 |
| 2026-08-15 | $5.46 | $7,446,229,447 | 5 / 7 |
| 2026-08-16 | $5.46 | $7,446,229,447 | 5 / 7 |
| 2026-08-17 | $5.46 | $7,446,229,447 | 5 / 7 |
| 2026-08-18 | $5.46 | $7,446,229,447 | 5 / 7 |
| 2026-08-19 | $5.46 | $7,446,229,447 | 5 / 7 |
| 2026-08-20 | $5.59 | $7,465,885,938 | 5 / 7 |
| 2026-08-21 | $5.59 | $7,465,885,938 | 6 / 7 |
| 2026-08-22 | $5.59 | $7,465,885,938 | 6 / 7 |
| 2026-08-23 | $5.59 | $7,465,885,938 | 6 / 7 |
| 2026-08-24 | $5.59 | $7,465,885,938 | 6 / 7 |
| 2026-08-25 | $5.59 | $7,465,935,068 | 6 / 7 |
| 2026-08-26 | $5.59 | $7,465,935,068 | 6 / 7 |
| 2026-08-27 | $5.59 | $7,465,935,068 | 6 / 7 |
| 2026-08-28 | $5.59 | $7,465,935,068 | 6 / 7 |
| 2026-08-29 | $5.60 | $7,467,635,068 | 6 / 7 |
| 2026-08-30 | $5.60 | $7,467,635,068 | 6 / 7 |
| 2026-08-31 | $5.60 | $7,467,635,068 | 6 / 7 |
| 2026-09-01 | $5.60 | $7,467,635,068 | 6 / 7 |
| 2026-09-02 | $5.60 | $7,467,635,068 | 6 / 7 |
| 2026-09-03 | $5.60 | $7,467,635,068 | 6 / 7 |
| 2026-09-04 | $5.63 | $7,508,404,970 | 6 / 7 |
| 2026-09-05 | $5.57 | $7,529,881,528 | 6 / 7 |
| 2026-09-06 | $5.57 | $7,529,881,528 | 6 / 7 |
| 2026-09-07 | $5.57 | $7,529,881,528 | 6 / 7 |
| 2026-09-08 | $5.57 | $7,529,881,528 | 6 / 7 |
| 2026-09-09 | $5.61 | $7,540,801,389 | 6 / 8 |
| 2026-09-10 | $5.61 | $7,540,801,389 | 6 / 8 |
| 2026-09-11 | $5.61 | $7,540,801,389 | 6 / 8 |
| 2026-09-12 | $5.61 | $7,540,801,389 | 6 / 8 |
| 2026-09-13 | $5.62 | $7,545,138,471 | 6 / 8 |
| 2026-09-14 | $5.62 | $7,545,138,471 | 6 / 8 |
| 2026-09-15 | $5.62 | $7,545,138,471 | 6 / 8 |
| 2026-09-16 | $5.62 | $7,545,138,471 | 6 / 8 |
| 2026-09-17 | $5.62 | $7,545,138,471 | 6 / 8 |
| 2026-09-18 | $5.62 | $7,545,138,471 | 6 / 8 |
| 2026-09-19 | $5.62 | $7,545,138,471 | 6 / 8 |
| 2026-09-20 | $5.62 | $7,545,093,017 | 6 / 8 |
| 2026-09-21 | $5.62 | $7,545,093,017 | 6 / 8 |
| 2026-09-22 | $5.62 | $7,545,093,017 | 6 / 8 |
| 2026-09-23 | $5.62 | $7,545,093,017 | 6 / 8 |
| 2026-09-24 | $5.62 | $7,545,093,017 | 6 / 8 |
| 2026-09-25 | $5.62 | $7,545,093,017 | 6 / 8 |
| 2026-09-26 | $5.62 | $7,545,093,017 | 6 / 8 |
| 2026-09-27 | $5.62 | $7,545,093,017 | 6 / 8 |
| 2026-09-28 | $5.62 | $7,545,093,017 | 6 / 8 |
| 2026-09-29 | $5.62 | $7,545,093,017 | 6 / 8 |
| 2026-09-30 | $5.62 | $7,545,093,017 | 6 / 8 |
| 2026-10-01 | $5.62 | $7,545,848,917 | 6 / 8 |
| 2026-10-02 | $5.62 | $7,545,848,917 | 6 / 8 |
| 2026-10-03 | $5.62 | $7,545,848,917 | 6 / 8 |
| 2026-10-04 | $5.62 | $7,545,848,917 | 6 / 8 |
| 2026-10-05 | $5.62 | $7,545,848,917 | 6 / 8 |
| 2026-10-06 | $5.62 | $7,545,848,917 | 6 / 8 |
| 2026-10-07 | $5.62 | $7,545,848,917 | 6 / 8 |
| 2026-10-08 | $5.62 | $7,545,848,917 | 6 / 8 |
| 2026-10-09 | $5.62 | $7,545,848,917 | 6 / 8 |
| 2026-10-10 | $5.62 | $7,545,848,917 | 6 / 8 |
| 2026-10-11 | $5.62 | $7,545,848,917 | 6 / 8 |
| 2026-10-12 | $5.62 | $7,545,848,917 | 6 / 8 |
| 2026-10-13 | $5.62 | $7,545,848,917 | 6 / 8 |
| 2026-10-14 | $5.62 | $7,545,848,917 | 6 / 8 |
| 2026-10-15 | $5.62 | $7,545,848,917 | 6 / 8 |
| 2026-10-16 | $5.62 | $7,545,848,917 | 6 / 8 |
| 2026-10-17 | $5.62 | $7,545,848,917 | 6 / 8 |
| 2026-10-18 | $5.62 | $7,551,360,265 | 7 / 9 |
| 2026-10-19 | $5.62 | $7,551,360,265 | 7 / 9 |
| 2026-10-20 | $5.64 | $7,553,526,932 | 7 / 9 |
| 2026-10-21 | $5.65 | $7,561,016,185 | 7 / 9 |
| 2026-10-22 | $5.65 | $7,561,016,185 | 7 / 9 |
| 2026-10-23 | $5.65 | $7,561,016,185 | 7 / 9 |
| 2026-10-24 | $5.65 | $7,561,016,185 | 7 / 9 |
| 2026-10-25 | $5.65 | $7,561,016,185 | 7 / 9 |
| 2026-10-26 | $5.65 | $7,561,016,185 | 7 / 9 |
| 2026-10-27 | $5.65 | $7,561,016,185 | 7 / 9 |
| 2026-10-28 | $5.65 | $7,561,016,185 | 7 / 9 |
| 2026-10-29 | $5.65 | $7,561,016,185 | 7 / 9 |
| 2026-10-30 | $5.65 | $7,561,016,185 | 7 / 9 |
| 2026-10-31 | $5.65 | $7,561,016,185 | 7 / 9 |
| 2026-11-01 | $5.65 | $7,561,016,185 | 7 / 9 |
| 2026-11-02 | $5.65 | $7,561,016,185 | 7 / 9 |
| 2026-11-03 | $5.65 | $7,561,016,185 | 7 / 9 |
| 2026-11-04 | $5.67 | $7,564,499,585 | 7 / 9 |
Revenue and EPS estimates track expectations. They are not delivered results or like-for-like proof of a required annual path.
Latest: 7 Buy / Strong Buy · 6 Hold · 0 Sell / Strong Sell
Recent actions · Oct 6–Nov 4 · 3 recorded
0 raises · 0 cuts · 0 unchanged · 1 without a comparable prior
Oct 6, 2026–Nov 4, 2026. Each firm's latest positive target is paired only with its immediately prior positive target from the same provider, at most 180 days earlier. Unmatched observations have one dot; conflicting observations are not compared.
3 of 4 published conditions remain under pressure or need verification. The next results need to address those conditions.
The dated weekly assessment and its assumptions are available in Read detailed Outlook.